BEIJING, Oct. 16, 2017 /PRNewswire/ -- Lianluo Smart Limited ("Lianluo" or the "Company") (Nasdaq: LLIT), a professionalintelligent smart service and products provider ináChina, today announced that the Company presented at the 28th Great Wall International Congress of Cardiology ("GW-ICC"), Asia Pacific Heart Congress 2017 ("APHC")and International Congress
Mr. Ping Chen, the CEO introduced Lianluo's sleep apnea syndrome(SAS) focused products and stated that, "we were pleased to present at the GW-ICC, APHC and ICCPR, which are the most influential annual international cardiovascular events with participants who are experts and academics in the health sector. We believe that participation in these leading industry events would benefit Lianluo to keep up with the most recent developments within the health sector, as well as to present and introduce our recent SAS products to participants worldwide. As studies show that SAS is a major factor associated with cardiovascular chronic diseases, and according to data of 2013 China Cardiovascular Diseases Report issued by National Center for Cardiovascular Diseases, that 70% - 80% of the 4.5 million cardiovascular patients in China were suffering from SAS. Therefore, SAS screening would greatly assist the chronic disease control, and SAS monitoring would greatly improve diagnosis accuracy by provide precise data to cardiologists. We expect our smart wearable SAS monitoring devices would bring convenience and accurate data to doctors and patients, and to contribute in academic studies of sleep and cardiovascular fields."
About The Great Wall International Congress of Cardiology
The Great Wall International Congress of Cardiology (GW-ICC) was founded in 1990 as a simple technical training course entitled, "International Great Wall Training Course -- Sino-US Radiofrequency Ablation Seminar". Fewer than 100 participants attended. From these humble beginnings, the Congress has grown from strength to strength. The Congress is now the largest and one of the most influential and successful comprehensive cardiovascular events in the Asian-Pacific region.
For additional information about the event, please click the link below:http://gw-icc2017.org/
AboutáLianluo Smart Limited
Lianluo Smart Limited is a professional intelligent smart service and products provider, which develops, markets and sells medical wearable devices, intelligent smart devices and ecosystem platform ináChina. The medical wearable devices sector's major products are wearable sleep respiratory devices. It provides medical-grade detection and monitoring to OSA (Obstructive Sleep Apnea) syndrome patients. The smart devices sector is specialized in easy-using smart devices for sports, social contact, entertainment, remote-control and family health management. The smart ecosystem platform interconnects things and things, things and human. Lianluo Smart is endeavoring to become a leading provider of intelligent smart products both in domestic and international markets. More information may be found atáwww.lianluosmart.com.
AT THE COMPANY:Ms. Mary Liáinvestor@lianluosmart.com
INVESTOR RELATIONS COUNSEL:The Equity Group Inc. Katherine Yao, Senior Associate Tel: +86 10 6587 email@example.com
View original content:http://www.prnewswire.com/news-releases/lianluo-smart-announces-presentation-in-major-international-cardiology-events-300536986.html
SOURCE Lianluo Smart Limited
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All